sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

North America Rnai Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00015136
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 123
Buy Now

North America RNAi Therapeutics Market Analysis, Scope, and Growth by 2027

Buy Now

North America RNAi Therapeutics Market Report North America RNAi Therapeutics Market Size and Share North America RNAi Therapeutics Market Scope and Analysis

North America RNAi Therapeutics Market Report Scope

Report Attribute Details
Market size in 2019 US$ 302.77 Million
Market Size by 2027 US$ 598.60 Million
Global CAGR (2020 - 2027) 9.0%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Molecule Type
  • Small Interfering RNAs
  • MicroRNA
By Application
  • Genetic Disorders
  • Oncology
  • Neurodegenerative Disorders
  • Cardiovascular
  • Respiratory Disorders
  • Infectious Diseases
  • Renal Diseases
By Route of Administration
  • Intradermal Injections
  • Pulmonary Delivery
  • Intravenous Injections
  • Intraperitoneal Injections
By End User
  • Diagnostic Laboratories
  • Research and Academic Laboratories
  • Hospitals
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Alnylam Pharmaceuticals Inc
  • Arrowhead Pharmaceuticals Inc
  • Quark
  • Rexahn Pharmaceuticals Inc
  • Arbutus Biopharma
    		•